Participant flow

Descartes-11 in Patients With Relapsed/Refractory Multiple Myeloma · Source last updated 2025-05-15

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. description

   Participants were administered 10 million cells of Descartes-11 via intravenous catheter on Days 7, 14 Participants were administered cyclophosphamide and Fludarabine on Days 1,2,3

   id

   FG000

   title

   Decartes-11 Dose Level 1

2. description

   Participants were administered cyclophosphamide and Fludarabine for pre-conitioning on Days 1,2,3 Participants were administered 32 million cells of Descartes-11 via intravenous catheter on Days 7, 14

   id

   FG001

   title

   Descates-11 Level 2

3. description

   Participants were administered cyclophosphamide and Fludarabine for preconditioning on Days 1,2,3 Participants were administered 100 million cells of Descartes- 11 on Days 7,14

   id

   FG002

   title

   Descartes-11 Dose Level 3

4. description

   Participants were administered Cyclophosphamide and Fludarabine for preconditioning on Days 1,2,3 Participants were administered 150 million cells of Descartes-11 via intravenous catheter on Days 7, 14,21

   id

   FG003

   title

   Descartes-11 Dose Level 4A

5. description

   Participants were administered Cyclophosphamide and Fludarabine for preconditioning on Days 1,2,3 Participants were administered 150 million cells of Descartes-11 via intravenous catheter on Days 7,10,14,17

   id

   FG004

   title

   Descartes-11 Dose Level 4B

6. description

   Participant did not receive preconditioning with cyclophosphamide or fludarabine, Participants were administered 150 million cells of Descartes-11 via intravenous catheter on Days 1,4,7,10,14,17

   id

   FG005

   title

   Descartes-11 Dose Level 4C

periods

1. milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         3

      2. group Id

         FG001

         num Subjects

         4

      3. group Id

         FG002

         num Subjects

         3

      4. group Id

         FG003

         num Subjects

         2

      5. group Id

         FG004

         num Subjects

         4

      6. group Id

         FG005

         num Subjects

         4

      type

      STARTED

   2. achievements

      1. group Id

         FG000

         num Subjects

         3

      2. group Id

         FG001

         num Subjects

         4

      3. group Id

         FG002

         num Subjects

         3

      4. group Id

         FG003

         num Subjects

         2

      5. group Id

         FG004

         num Subjects

         4

      6. group Id

         FG005

         num Subjects

         4

      type

      COMPLETED

   3. achievements

      1. group Id

         FG000

         num Subjects

         0

      2. group Id

         FG001

         num Subjects

         0

      3. group Id

         FG002

         num Subjects

         0

      4. group Id

         FG003

         num Subjects

         0

      5. group Id

         FG004

         num Subjects

         0

      6. group Id

         FG005

         num Subjects

         0

      type

      NOT COMPLETED

   title

   Overall Study

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice